News

The state of the art technique can improve hearing in children and adults with congenital deafness or severe hearing ...
The state-of-the-art technique can improve hearing in children and adults with congenital deafness or severe hearing ...
By 2030, the cell and gene therapy market is projected to be worth £76.03bn, and logistics is essential in realising the ...
ProBio opens a 128,000-sq.-ft. gene therapy facility in Hopewell, creating 110+ jobs and advancing global cell and gene ...
ProBio, a global contract development and manufacturing organization (CDMO) specializing in cell and gene therapy, today ...
Ferring USA in Parsippany employs more than 900 individuals. Ferring Pharmaceuticals officially opened doors to its state-of-the-art gene therapy manufacturing facility in Parsippany June 17, 2025.
HIV remains incurable but manageable. Johns Hopkins found a way to silence it long-term using a molecule from the virus ...
Post-COVID data show that circulatory claims have increased by nearly 60%, while neoplasms remain the leading source of ...
EVA Pharma is one of the fastest-growing healthcare companies in the Middle East and Africa, with an extensive pan-African presence, while operating in more than 70 countries worldwide. For more ...
Last month, a baby got the world’s first personalized gene-editing treatment. What will this mean for millions of others with ...
Open House Highlights Expanded Sterile Filling Contract Manufacturing Capabilities for Small and Large Molecules Pace Life Sciences Salem Renderings ...
EVA Pharma Deepens Its Roots in China’s Thriving Biopharmaceutical Ecosystem with The Inauguration of Its Hangzhou ...